US Patent Issued to MINOMIC INTERNATIONAL on May 5 for "Biomarker combinations for determining aggressive prostate cancer" (Australian Inventors)

ALEXANDRIA, Va., May 5 -- United States Patent no. 12,618,843, issued on May 5, was assigned to MINOMIC INTERNATIONAL LTD. (New South Wales, Australia).

"Biomarker combinations for determining aggressive prostate cancer" was invented by Douglas Campbell (New South Wales, Australia), Thao Ho-Le (New South Wales, Australia), Brad Walsh (New South Wales, Australia) and Rachel Levin (New South Wales, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for the diagnosis of aggressive prostate cancer, including, but not limited to, methods for discerning between aggressive and non-aggressive forms of prostate cancer, and methods for detecting aggressive prostate cancer b...